Thank you very much for the submission of your research manuscript to our editorial office and for your patience while we were waiting to hear back from the referees. We have now received the full set of reviews on your manuscript.
Thank you very much for the submission of your research manuscript to our editorial office and for your patience while we were waiting to hear back from the referees. We have now received the full set of reviews on your manuscript.
As the detailed reports are pasted below I will only repeat the main points here. You will see that all reviewers appreciate the interest of your findings and are, in principle, supportive of publication of your study in our journal. However, they are also in agreement that several aspects of your data need to be improved before the paper can be published. For example, referees 1 and 2 both agree that stronger proof for mTORC1 activity is needed and reviewer 1 also states that the expression of mTORC1 should be checked in the different SPC subpopulations. Functionally, this referee also feels that evidence should be provided that the different subsets of cells differ in their stemness/repopulation capacity. Along similar lines, referee 2 points out that the different SPC subpopulations should be tested for differences in (stem cell) marker expression. Finally, reviewer 3 states that evidence for mTORC1 induction in spermatogonia under physiological conditions is needed.
Overall, and given the reviewers' constructive comments, I would like to give you the opportunity to revise your manuscript, with the understanding that the main concerns of the reviewers should be addressed. Acceptance of the manuscript will depend on a positive outcome of a second round of review and I should also remind you that it is EMBO reports policy to allow a single round of revision only and that therefore, acceptance or rejection of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript.
I look forward to seeing a revised form of your manuscript when it is ready. Should you in the meantime have any questions, please do not hesitate to contact me.
REFEREE REPORTS:
Referee #1:
In this manuscript Hobbs and colleagues describe two distinct germline progenitor subsets based on the use of genetic mTORC1 activation. Deletion of the mTORC1 regulator TSC2 using Cre recombinase under the control of Stra-8 promotor suggested that mTORC1 is not needed for spermatogenesis. However, it appeared that this did not fully delete TSC2 in all SPCs but only resulted in mTORC1 activation in a subset. In agreement full deletion in the complete germline did affect long-term spermatogenesis. This indicates that distinct subsets of SPCs can be defined in the germline and that these have a differential dependency on mTORC1 activity.
These data are certainly of interest and provide the tools to identify a long-term SPC in the testis. However, several key issues remain that would need to be addressed.
1. It would be good to validate the expression of mTORC1 in the distinct subsets. Activation by TSC2 deletion obviously only works if mTORC1 is expressed. This needs to be validated and compared between the subsets.
2. In line with this it would be good to validate the actually activity of mTORC1 in the subsets using S6 phosphorylation. The authors have the tools to separate the two subsets and it would be needed to prove some of the claims on mTORC1 activity in these subsets.
3. The authors suggest that mTORC1 activation leads to an increase in size of the SPCs. However, the same increase in size is reported for the Z/EG floxed setting suggesting that this is more a representation of the distinct subsets than a result of mTORC1 activity. The authors need to comment and check with in the rapamycin-treated setting for cell sizes. 4 . Finally, the most important part is the claim that these SPC subsets represent SPCs with distinct capacity to repopulate the testis in long-term assays. This needs to be validated using transfer experiment. It is a critical conclusion of the manuscript but stemness is not measured at all. This can be done easily with the Z/EG mice which allows isolation of the SPC subsets in the STRA-8 setting.
Referee #2:
It is yet unclear whether the mammalian spermatogenesis is maintained by a unique and homogenous stem cell population or through distinct heterogeneous undifferentiated cell populations characterized by distinct gene expression. Here, Hobbs et al. proposed that mTORC1 signalling responses are responsible for stem cell heterogeneity and regulate their self-renewal and differentiation.
The authors claim to identify distinct subsets of undifferentiated spermatogonia (SPCs) based on a differential response to mTORC1 hyper activation. They hyper activate mTORC1 signalling by conditionally deleting its endogenous inhibitor Tsc2, in juvenile and adult male mice. They first showed that in wild-type mice mTORC1 activity (measured by P-RPS6 immunostaining) is heterogeneous. Then, by deleting Tsc2 using the Vasa-Cre transgene, the authors demonstrate that mTORC1 acts cell-autonomously, and has a major role in the maintenance of the germline stem cells. The Tsc2-Vasa-Cre mice presented a decrease in SPC markers and a defect of differentiation. They also demonstrated that Rapamycin rescued the phenotype of the KO, supporting the notion that the phenotype is really dependent on mTORC1 activity. Conversely, the Tsc2 ablation using the Stra8-Cre transgene, another CRE expressed in SPCs does not result in any SPCs dysfunctions, suggesting that the two CREs marked different populations of SPCs. Finally the authors showed deleting Tsc2 in the Sertoli cells leads only to a transient in juvenile, but not any phenotype in young adult mice, suggesting that mTOR may also play a non cellular autonomous role in regulating spermatogenesis.
While the requirement for mTORC1 in the control of self-renewal vs. differentiation of the SPCs is well supported by the experiments (in line with the previous papers of the authors), the evidence for the existence of distinct SPCs populations based on the different phenotypes of Tsc2 deletion using the two different CREs are frankly weak.
Major points:
1-Throughout the paper the authors use only P-RPS6 and the cell size of the cell, measured by FSC, as read-out of mTORC1 activity. It would be of great interest to verify the heterogeneity of mTORC1 activity in wild-type testis also in other experimental ways (i.e. with the phosphorylation of 4EBP1, activation of TIF-1A, phosphorylation of Maf1 or by Real-Time PCR for specific mTORC1 target genes).
2-In page 10 the authors claimed that mTORC1 activity increases in a graded mode from Stra8-Creneg (where mTORC1 activity is low), to Stra8-Crepos (where mTORC1 activity is intermediate) and to cells initiating differentiation (where mTORC1 is high). This conclusion is based only on cells size, measured by FSC. Could the authors show a graded increase of others biological/physical markers of mTORC1 activity?
3-In order to demonstrate that they identify different SPCs populations with the Stra8-Cre, they should FACS isolated the different populations and performed transcriptional profiling so to identify markers of the two distinct cell populations. Moreover the authors propose that Stra8-Crepos cells represent a subpopulation of SPCs with a lower self-renewal capacity, resembling the Ngn3+ Aal progenitor pool. They should provide quantification of the expression of Ngn3 in the Stra8-Crepos cells. Conversely, as Stra8-Creneg SPCs have decreased mTORC1 activity, the authors proposed that they could be predicted to have a higher self-renewal capacity, equivalent to the Gfra1+ As and Apr population. They should provide quantification of the expression of GFRa1 and Nanos2. Do the different populations really present distinct fate?
Minor points:
1-Authors should quantify co-immunofluorescence of Figure 1B. 2-Authors should indicate in the abstract that they used the Vasa-Cre driver to promote differentiation in SPCs.
In conclusion, the experiments do not support completely the findings drawn and the paper seems incomplete. For all this reasons I would invite the authors to revise the manuscript.
Referee #3:
In this manuscript, the authors identify different subpopulations of undifferentiated spermatogonia according to differential mTORC1 activity through conditional deletion of the mTORC1 inhibitor Tsc2 using Stra8-Cre and Vasa-Cre strategies, respectively. The manuscript is well-written and should be accepted for publishing in EMBO after fixing the following issues.
Comments: 1. The major conclusion in this manuscript is that the activation of mTORC1 is highly related with the differentiation of spermatogonia. However, there was no direct evidence to show that mTORC1 expression was activated in differentiating spermatogonia in physiological situation. It might be easy to isolate different spermatogonia probably according to the different cell size, as the authors described in the manuscript, and analyze the mRNA levels of mTORC1 in these cells. 2. This referee is wondering about the fertility of Tsc2F/F Stra8-Cre mice and Tsc2F/△ Vasa-Cre. 
Reviewer #1
Major Comments.
Expression of mTORC1 pathway components in the SPC pool.
As correctly highlighted by the reviewer, Tsc2 deletion in SPC subsets will only result in aberrant mTORC1 activation if pathway components are expressed. Given that the mTORC1 pathway is the primary target of the TSC complex [1] , ubiquitous expression of Tsc2 throughout the SPC pool ( Fig   2G and 4F) would suggest that the mTORC1 pathway can operate within all SPCs. Regardless, we now confirm that the mTOR kinase itself plus the key downstream target 4EBP1 are ubiquitously expressed within the SPC pool ( Supplementary Fig 2) . Further, when performing whole mount analysis on wildtype seminiferous tubules using antibodies specific to phosphorylated and nonphosphorylated 4EBP1, a direct target of the mTORC1 kinase complex, we obtain a reciprocal staining pattern within the SPC population ( Figs 1C and 1E ). Together, these results demonstrate that while mTORC1 pathway activity varies in distinct SPC subsets in a wildtype setting, all cells within the population would have the capacity to activate the pathway in response to Tsc2 deletion.
Of note, we have previously demonstrated that cultured SPCs express key components of the TSCmTORC1 axis at the protein level, including Tsc1, Tsc2, Rheb and mTOR [2] .
Characterizing mTORC1 pathway activity within SPC subsets.
In order to better characterize differential mTORC1 activity within the SPC pool we now include whole mount analysis of wildtype seminiferous tubules using multiple markers of mTORC1 activity (Fig 1) . In adults the phosphorylation of ribosomal protein S6 (RPS6), a widely used indicator of mTORC1 activity, is primarily detected in long cysts of spermatogonia with low or absent Plzf expression, i.e. differentiating spermatogonia (Fig 1B) . This data is in agreement with our previous immunohistochemistry data ( Fig 1A) . However, as we note in the manuscript, while phospho-RPS6 is a commonly used readout of mTORC1 activation and Tsc2 deletion results in substantial increases in phospho-RPS6 levels (Figs 1H and 3B), this marker may not provide the most sensitive or direct measure of mTORC1 activity. Specifically, phosphorylation of RPS6 is induced indirectly through mTORC1-dependent phosphorylation and activation of the upstream ribosomal S6 kinases (S6Ks).
Further, S6Ks are phosphorylated and regulated by other kinases besides the mTORC1 complex, e.g. Pdk1, and thus integrate multiple regulatory inputs [3] . In addition, S6Ks are relatively poor, low affinity substrates for mTORC1 when compared to other direct targets [4] . We have therefore used phospho-4EBP1 as an additional and more sensitive marker of mTORC1 activity given that it is directly phosphorylated by mTORC1 and is a high-affinity target [4] .
Importantly, whole mount immunostaining of adult wildtype seminiferous tubules with antibodies to phospho-4EBP1 indicates a striking heterogeneity of mTORC1 activity within the Plzf-positive SPC pool ( Fig 1C) . We demonstrate that longer SPC cysts (A al ) stain significantly more frequently for phospho-4EBP1 than short-chain cysts (A s and A pr ) ( Fig 1D) . Given that increasing SPC cyst length is positively correlated with enhanced differentiation tendencies [5] , these results suggest that the mTORC1 pathway is preferentially active in differentiation-committed cells. This conclusion is supported by the low frequency of phospho-4EBP1 staining within Gfrα1-positive SPCs, primarily representing short chain SPC cysts, a population that contains the majority of self-renewing cells under steady-state conditions ( Fig 1F and Supplementary Fig 1A) [6]. In contrast, markers reported to be preferentially associated with committed progenitors within the SPC pool, e.g. Lin28a, correlated strongly with phospho-4EBP1 staining (Supplementary Fig 1C) [7] .
Based on these and previous observations, it is clear that mTORC1 pathway activity in the SPC pool is heterogeneous and preferentially associated with differentiation-prone SPC subsets. Given that aberrant mTORC1 activation in SPCs induced by efficient Vasa-Cre-mediated deletion of Tsc2 results in increased differentiation commitment and germline degeneration, we conclude that differential mTORC1 activation underlies the distinct differentiation and self-renewal propensities of SPC subsets.
We had previously taken advantage of the Stra8-Cre transgene to delineate subsets of SPCs displaying characteristics of increased mTORC1 activation (elevated cell size), which were insensitive to further mTORC1 activation through Tsc2 deletion. In this context, use of the Credependent GFP reporter line ZEG allowed us to identify cells expressing Stra8-Cre or those derived from cells that had previously expressed the transgene. We have now performed an extensive assessment of the pattern of Stra8-Cre activity within the SPC pool by whole mount analysis in order to confirm the relationship to differentiation commitment and mTORC1 activation. These results are presented together in Figure 6 and Supplementary Fig 5. Importantly, as suggested by our previous flow cytometry analysis (Fig 6A-C) , we find preferential Stra8-Cre expression in mTORC1-active A al subsets while GFP negative Plzf positive cells are typically A s and A pr and P-4EBP negative/low ( Fig 6D) . Further, we demonstrate that Stra8-Cre expression is significantly more evident in committed progenitors than the self-renewing fraction of SPCs (see detailed discussion below). As mTORC1 is more active in differentiation committed versus self-renewing SPC populations, these data support our conclusion that Stra8-Cre expression is preferentially associated with mTORC1-active SPC subsets.
Association between mTORC1 activity and SPC cell size.
While changes in cell size are closely associated with manipulation of the mTORC1 pathway [8, 9] , we agree with the reviewer that differences in cell size may not necessarily indicate changes to mTORC1 activity but may simply reflect varying physical characteristics of distinct cell populations and types. However, in this context we are confident that cell size changes within the SPC pool delineate changes in mTORC1 pathway status. For instance, the cell size differences between Stra8-Cre neg and Stra8-Cre pos SPC subsets in the Stra8-Cre; ZEG mice are lost upon treatment with the mTORC1 inhibitor rapamycin (Fig 6B) . Further, Stra8-Cre is preferentially expressed by committed progenitors within the SPC pool, the same SPC fraction that displays mTORC1 activation (see above). As anticipated from these observations, we also demonstrate a direct association between
Stra8-Cre expression and mTORC1 pathway activity (Fig 6D) . Lastly, we now include data
showing that the increased cell size of SPCs associated with Vasa-Cre-mediated Tsc2 deletion is also rescued by treatment with rapamycin ( Supplementary Fig 3C) .
Stem cell potential of the distinct SPC subsets.
We agree with the reviewer that it is critical to determine the role of mTORC1 high and low SPC subsets, distinguished through differential Stra8-Cre expression, to long-term germline maintenance. Specifically, we predict that mTORC1 high, Stra8-Cre positive SPCs are differentiation prone while mTORC1 low, Stra8-Cre negative cells have higher self-renewal potential. We now provide multiple lines of evidence to address this point.
As discussed above, through whole mount analysis of wildtype seminiferous tubules, we now demonstrate that mTORC1 activity within the SPC pool, as defined by 4EBP1 phosphorylation, correlates strikingly with well-established indicators of differentiation commitment. For instance, the fraction of Plzf-positive cysts staining positive for phospho-4EBP1 is significantly higher in longer A al cysts when compared with shorter A s cells and A pr cysts (Fig 1C and 1D) . Although cyst length within the SPC pool is not absolutely correlated with the tendency to differentiate it is a strong indicator of this fate propensity. Short cysts and single cells more frequently express Gfra1, a marker for cells with high self-renewal potential, while longer A al cysts predominantly express
Ngn3, make a minimal contribution to long-term germline maintenance in the steady state testis and typically differentiate [5, 6] . Correspondingly, from this data it can be proposed that mTORC1 activation is predominantly observed within those SPC subsets with a high propensity to differentiate and low self-renewal potential.
In support of this prediction, we find that the Gfrα1-positive self-renewing SPC population contains a very limited proportion of phospho-4EBP1-positive cells/cysts; between 13 and 17% of Gfrα1-positive A s cells and A pr cysts are phospho-4EBP1 positive ( Fig 1F and Supplementary Fig   1A) . Note that the size distribution of Gfrα1 cysts we observe closely matches previous reports ( Supplementary Fig 1B) [6] . In comparison, approx. 60% and 90% of Plzf-positive A al4 and A al≥8 cysts stain for phospho-4EBP1 (Fig 1C and 1D ). Tools to detect the Ngn3-expressing population are limited given the absence of appropriate antibodies and typical reliance on GFP reporter strains [10] .
Therefore, we provide data demonstrating that phospho-4EBP1 levels are strongly associated with expression of Lin28a (Supplementary Fig 1C) . This marker has been demonstrated to preferentially mark committed progenitors within the SPC pool [7] . Combined, our whole mount analysis provides strong evidence linking mTORC1 activation to differentiation commitment fate decisions within the SPC pool.
Besides comparing activity of the mTORC1 pathway itself in self-renewing and differentiationcommitted SPC subsets, we have in addition performed a more detailed assessment of Stra8-Cre expression within the SPC pool. Taking advantage of the ZEG Cre-dependent GFP reporter line, we had previously determined by flow cytometry that Stra8-Cre activity was heterogeneous within the Plzf pos c-Kit neg SPC pool (Fig 6A) . Moreover, that Stra8-Cre expression predominated within those
SPCs that displayed signs of increased mTORC1 activation i.e. mean cell size (FSC) was larger than
Stra8-Cre negative SPCs and size was normalized through treatment with the mTORC1 inhibitor rapamycin (Fig 6B and 6C) . We have now extended this flow cytometry analysis through additional whole mount analysis as follows: 1) We have confirmed the heterogeneity of Stra8-Cre expression within the Plzf-positive SPC pool in both juvenile and adult Stra8-Cre; ZEG tubules ( Supplementary   Fig 5A) . 2) By comparison of GFP expression to phospho-4EBP1 in Plzf-positive cells and cysts we observe preferential Stra8-Cre expression within mTORC1-active A al subsets (Fig 6D) . Conversely, we find a striking heterogeneity of Stra8-Cre activity in both adult and juvenile samples (Fig 6E, 6F and Supplementary 5B). In contrast, essentially all committed A al SPCs and spermatogonia at the earliest stages of differentiation (A1), identified through selective expression of retinoic acid receptor gamma (RARγ) [11, 12] , express or have expressed Stra8-Cre (Fig 6E, 6F and Supplementary 5C). In this context, RARγ provides a convenient marker to delineate committed SPC fractions and spermatogonial progenitors. Importantly, we confirm that Gfrα1 and RARγ mark distinct spermatogonial pools in agreement with previous reports (Supplementary Fig 5D) [12] . As would be expected, the RARγ positive SPC subset displays characteristic features of increased mTORC1 activity compared to RARγ negative SPCs including increased cell size (Fig 6G and Supplementary Fig 5E) .
Taken together, this new data demonstrates that Stra8-Cre is preferentially, although not exclusively, active within mTORC1-active committed progenitor fractions versus mTORC1-low self-renewing fractions (Fig 6F) . Given that deletion of two floxed Tsc2 alleles is likely less efficient than recombination of a single ZEG reporter transgene, this differential Cre expression is predicted to result in substantially more efficient Tsc2 deletion in differentiation-committed than selfrenewing fractions. The model and text have been updated to reflect this data (Fig 6H) .
In view of recent reports suggesting that the Gfrα1-positive population is itself heterogeneous and that stem cell function is confined to a small fraction of these cells [13, 14] , it can be relevant that we find Stra8-Cre to be active in a subset of Gfrα1-positive cells in both juvenile and adult animals ( Fig 6E and Supplementary Fig 5B) . Interestingly, the mTORC1 pathway is also active in a fraction of the Gfrα1-positive population ( Supplementary Fig 1A) , together implying that Stra8-Cre expression and/or mTORC1 activity could also delineate distinct populations of Gfrα1-positive cells. However, it should be noted that based on in vivo lineage-tracing and live imaging studies, it is proposed that in the steady state testis the Gfrα1-positive population forms an equipotent stem cell pool [6] , seemingly at odds with these other reports.
As discussed by the reviewer, an additional experimental approach to assess stem cell potential of these distinct SPC subsets would be to perform transplantation assays. However, a technical limitation to this approach concerns the manner in which we identify Stra8-Cre positive and negative SPC subsets by flow cytometry. Specifically, testis cells are fixed and permeabilized then immunostained for the intracellular SPC marker Plzf, thus precluding use of this method to isolate viable cells. Given the striking results of the whole mount analysis linking both mTORC1 activity and Stra8-Cre expression with differentiation-committed SPC subsets, the required development of additional cell surface marker-based systems for SPC isolation and subsequent transplantation is beyond the scope of the current study. Further, it remains unclear whether transplant-competent cells are entirely equivalent to those SPC populations that are responsible for germline maintenance in the steady state tissue and which can be identified through whole mount analysis [5, 6, 14, 15] .
Reviewer #2
Heterogeneity of mTORC1 activity within the SPC pool.
As suggested by the reviewer, in order to better characterize differential mTORC1 activity within the SPC pool we now include whole mount analysis of wildtype seminiferous tubules using multiple markers of mTORC1 activity (Fig 1) . In adults the phosphorylation of ribosomal protein S6 (RPS6), a widely used indicator of mTORC1 activity, is primarily detected in long cysts of spermatogonia with low or absent Plzf expression, i.e. differentiating spermatogonia (Fig 1B) . This data is in agreement with our previous immunohistochemistry data (Fig 1A) . However, as we now note in the manuscript, while phospho-RPS6 is a commonly used marker of mTORC1 activation and Tsc2 deletion results in substantial increases in phospho-RPS6 levels (Figs 1H and 3B), this marker may not provide the most sensitive and direct measure of mTORC1 activity. Specifically, phosphorylation of RPS6 is induced indirectly through mTORC1-dependent phosphorylation and activation of ribosomal S6 kinases (S6Ks). Further, S6Ks are phosphorylated and regulated by other kinases besides mTORC1, e.g. Pdk1, and integrate multiple regulatory inputs [3] . In addition, S6Ks are relatively poor, low affinity substrates for mTORC1 when compared to other direct targets [4] .
We have therefore used phospho-4EBP1 as an additional and more sensitive marker of mTORC1 activity given that it is directly phosphorylated by the complex and is a high-affinity target [4] .
Importantly, whole mount immunostaining of adult wildtype seminiferous tubules with antibodies to phospho-4EBP1 indicates a striking heterogeneity of mTORC1 activity within the Plzf-positive SPC pool (Fig 1C) . We demonstrate that longer SPC cysts (A al ) stain significantly more frequently for phospho-4EBP than short-chain cysts (A s and A pr ) (Fig 1D) . Although cyst length within the SPC pool is not absolutely correlated with the tendency to differentiate it is a strong indicator of this fate propensity. Short cysts and single cells more frequently express Gfra1, a marker for cells with high self-renewal potential, while longer A al cysts predominantly express
In support of this prediction, we find that the Gfrα1-positive self-renewing SPC population contains a very limited proportion of phospho-4EBP1-positive cells/cysts; between 13 and 17% of Gfrα1-positive A s cells and A pr cysts are phospho-4EBP1 positive (Fig 1F and Supplementary Fig   1A) . Note that the size distribution of Gfrα1 cysts we observe closely matches previous reports ( Supplementary Fig 1B) [6] . In comparison, approx. 60% and 90% of Plzf-positive A al4 and A al≥8
cysts stain for phospho-4EBP1 (Fig 1C and 1D ). Tools to detect the Ngn3-expressing population are limited given the absence of appropriate antibodies and typical reliance on GFP reporter strains [10] .
Therefore, we also provide data demonstrating that phospho-4EBP1 levels are strongly associated with expression of Lin28a (Supplementary Fig 1C) . This marker has been demonstrated to preferentially mark committed progenitors within the SPC pool [7] .
Based on these and previous observations, it is clear that mTORC1 pathway activity in the SPC pool is heterogeneous and preferentially associated with those SPC subsets with high propensity for differentiation. Given that aberrant mTORC1 activation in SPCs induced by efficient Vasa-Cre mediated deletion of Tsc2 results in increased differentiation commitment and ultimately germline degeneration, we conclude that this differential activation of mTORC1 underlies distinct differentiation and self-renewal propensities of SPC subsets.
Changes in mTORC1 activity during differentiation commitment.
As commented by the reviewer, we provide evidence to suggest that mTORC1 activity increases in a graded fashion from Stra8-Cre negative SPCs to Stra8-Cre positive SPCs to cells positive for both
Plzf and c-Kit, representing spermatogonia at early steps in the differentiation pathway. While this conclusion was based on incremental changes in cell size as measured by flow cytometry, we would like to emphasize the close association we observe between cell size within the SPC and spermatogonial pool and mTORC1 pathway activity. For instance, the cell size differences between Stra8-Cre neg and Stra8-Cre pos SPC subsets in the Stra8-Cre; ZEG mice are lost upon treatment with the mTORC1 inhibitor rapamycin (Fig 6B) . In addition, we include data showing that the increased cell size of SPCs associated with Vasa-Cre-mediated Tsc2 deletion is also rescued by treatment with rapamycin ( Supplementary Fig 3C) . Unfortunately, flow cytometry analysis for more direct indicators of mTORC1 activity i.e. phospho-RPS6 and phospho-4EBP1 is often unsuccessful.
Potentially, during the enzymatic procedure to generate single cell suspensions from testis, the mTORC1 pathway is downregulated and these dynamic marks lost. The concept of a graded increase in mTORC1 activity between SPC populations and differentiation spermatogonia is also supported by reports demonstrating an important role for mTORC1 downstream the c-Kit receptor in cell cycle progression of differentiating spermatogonia and that the key SPC self-renewal factor GDNF does not efficiently activate the mTORC1 pathway in cultured SPCs [2, 16] .
To provide further support for our flow cytometry analysis we have performed whole mount analysis for other indicators of mTORC1 activity within SPCs and spermatogonia. As detailed above we now demonstrate that differentiation-prone A al SPC subsets are frequently positive for phospho-4EBP1, a direct and high affinity mTORC1 target. In contrast, the majority of selfrenewing Gfrα1-positive A s and A pr cells are phospho-4EBP1 negative. While populations of differentiating spermatogonia are also phospho-4EBP1 positive, it is clear that the mTORC1-4EBP1
axis is regulated in a dynamic fashion during spermatogenesis. In particular, use of an antibody specific for non-phospho-4EBP1 stains Plzf-positive A s and A pr cells as anticipated but also marks late differentiating cells including B spermatogonia and pre-leptotene spermatocytes (Fig 1E) . This suggests that mTORC1 activity is low in self-renewing SPC populations, is active in differentiationcommitted progenitors and differentiating spermatogonia but is downregulated again prior to entry into meiosis. In connection to our analysis of 4EBP1 phosphorylation during commitment of wildtype SPCs, we also confirm the connection between Stra8-Cre expression and mTORC1 activity using a similar approach. By comparison of GFP expression in both juvenile and adult
Stra8-Cre; ZEG testis to phospho-4EBP1 in Plzf-positive cells and cysts we observe preferential
Stra8-Cre expression within mTORC1-active A al subsets (Fig 6D) . Conversely, GFP negative Plzf positive cells are typically A s and A pr and P-4EBP negative/low.
As discussed above, RPS6 is indirectly phosphorylated by mTORC1, which acts through phosphorylation of S6Kinases, relatively poor substrates for the mTORC1 kinase complex [4] . Tsc2 deletion does however result in robust increases in RPS6 phosphorylation, indicating that the mTORC1 pathway is strongly stimulated in this setting. In the adult germline, phospho-RPS6 levels are low within the SPC pool and most apparent in differentiating spermatogonia (Fig 1B) . Given that efficient signaling through the mTORC1-S6K-RPS6 axis requires a higher overall level of mTORC1 activation than mTORC1-dependent 4EBP1 phosphorylation [4] , it can be concluded that the distinct patterns of 4EBP1 and RPS6 phosphorylation we observe in SPC subsets and differentiating spermatogonia indicate the relative levels to which mTORC1 is activated.
Specifically, self-renewing SPCs have low mTORC1 activity and therefore stain weakly for both phospho-4EBP1 and phospho-RPS6. Differentiation-prone SPC subsets have an intermediate This model, based on whole mount analysis, is consistent with our previous flow-cytometry data.
However, it is also possible that the restriction of mTORC1-S6K-RPS6 signaling to differentiating spermatogonia is also reflective of additional regulatory inputs to S6K. For example, the phosphorylation of S6K by mTORC1 creates a docking site for phosphoinositide-dependent kinase 1 (PDK1), which then phosphorylates S6K at an additional site to activate the kinase [3] . It can therefore be relevant that deletion of Pdk1 in the male germline results in a striking block in spermatogonial differentiation while SPC maintenance appears relatively unaffected [17].
3. Identity of Stra8-Cre pos and Stra8-Cre neg SPC fractions.
We agree with the reviewer that it is important to characterize in more detail the SPC subsets distinguished through differential Stra8-Cre expression and corresponding mTORC1 activity.
Specifically, we predict that Stra8-Cre positive, mTORC1 high SPCs represent differentiation prone subsets while Stra8-Cre negative, mTORC1 low cells represent the self-renewing fraction. We now provide multiple lines of evidence to address this point.
As discussed above we have confirmed by whole mount analysis that markers of mTORC1 activity correlate significantly with well-established indicators of differentiation commitment within the SPC pool. Besides this comparison of mTORC1 pathway activity itself in self-renewing and differentiation-committed SPC subsets, we have also performed a more detailed assessment of Stra8-Cre expression within the SPC pool as requested. Taking advantage of the ZEG Credependent GFP reporter line, we had previously determined by flow cytometry that Stra8-Cre activity was heterogeneous within the Plzf pos c-Kit neg SPC pool (Fig 6A) . Moreover, that Stra8-Cre expression predominated within those SPCs that displayed signs of increased mTORC1 activation
i.e. mean cell size (FSC) was larger than Stra8-Cre negative SPCs and size was normalized through treatment with the mTORC1 inhibitor rapamycin (Fig 6B and 6C) .
We have now extended this flow cytometry analysis through additional whole mount analysis as follows: 1) We have confirmed the heterogeneity of Stra8-Cre expression within the Plzf-positive SPC pool in both juvenile and adult Stra8-Cre; ZEG tubules ( Supplementary Fig 5A) . 2) By comparison of GFP expression with phospho-4EBP1 in Plzf-positive cells and cysts we observe preferential Stra8-Cre expression within mTORC1-active A al subsets (Fig 6D) . Conversely, GFP negative Plzf positive cells are typically A s and A pr and P-4EBP negative/low. 3) A detailed comparative assessment of Stra8-Cre activity has now been performed in self-renewing and differentiation committed cell populations. Within the self-renewing Gfrα1-positive SPC fraction, we find a striking heterogeneity of Stra8-Cre activity in both adult and juvenile samples (Fig 6E, 6F and Supplementary 5B). In contrast, essentially all committed A al SPCs and spermatogonia at the earliest stages of differentiation (A1), identified through selective expression of retinoic acid receptor gamma (RARγ) [11, 12] , express or have expressed Stra8-Cre (Fig 6E, 6F and Supplementary 5C). In the absence of appropriate antibodies to markers such as Ngn3 that also label differentiation-prone SPC subsets, RARγ expression conveniently delineates committed SPC fractions and spermatogonial progenitors. Importantly, we confirm that Gfrα1 and RARγ mark distinct spermatogonial pools in agreement with previous reports (Supplementary Fig 5D) [12] . As would be expected, the RARγ positive SPC subset displays characteristic features of increased mTORC1 activity compared to RARγ negative SPCs including increased cell size (Fig 6G and Supplementary Fig 5E) .
Taken together, this new data demonstrates that Stra8-Cre is preferentially, although not exclusively, active within mTORC1-active committed progenitor fractions versus mTORC1-low self-renewing fractions (Fig 6F) . Given that deletion of two floxed Tsc2 alleles is most likely less efficient than recombination of a single ZEG reporter transgene, this differential Cre expression is predicted to result in substantially more efficient Tsc2 deletion in differentiation-committed than self-renewing fractions. The model and text have been updated to reflect this data (Fig 6H) .
In view of recent reports suggesting that the Gfrα1-positive population is itself heterogeneous and that stem cell function is confined to a small subset of these cells [13, 14] , it can be relevant that we find Stra8-Cre to be active in a subset of Gfrα1-positive cells in both juvenile and adult animals ( Fig 6E and Supplementary Fig 5B) . Interestingly, the mTORC1 pathway is also active in a fraction of the Gfrα1-positive population ( Supplementary Fig 1A) , together implying that Stra8-Cre expression and/or mTORC1 activity could also delineate distinct populations of Gfrα1-positive cells. However, it should be noted that based on in vivo lineage-tracing and live imaging studies, it is proposed that in the steady state testis the Gfrα1-positive population forms an equipotent stem cell pool [6] , seemingly at odds with these other reports.
As mentioned by the reviewer, to be able to purify and transcriptionally profile Stra8-Cre positive and negative SPC subsets for genes specific to self-renewing and differentiation-committed fractions would have been informative. However, in this manuscript we primarily identify SPC subsets according to expression of the intracellular marker Plzf, which requires fixing and permeabilizing cells. In our experience, the quality of RNA derived from fixed cells in this protocol is low and prevents transcriptional analysis. We have therefore provided an alternative whole-mount based analysis as detailed above.
Minor Points.
Quantification of Plzf/P-S6 immunostaining.
To define the heterogeneity of mTORC1 pathway activity within Plzf-positive SPCs, we now provide quantification of phospho-4EBP1 staining within Plzf positive cysts from whole mount immunostaining of adult seminiferous tubules (Fig 1D) . This provides an additional advantage over scoring Plzf positive SPCs from sections in that cyst length provides an indicator of propensity to differentiate [5] . Note that in the adult, phospho-RPS6 staining is primarily observed in Plzf low/negative differentiating spermatogonia (Fig 1B) .
Abstract modification.
As requested, we now mention use of the Vasa-Cre deletor strain in a modified abstract.
Reviewer #3
Changes in mTORC1 activity during differentiation commitment.
As suggested by the reviewer, in order to better characterize mTORC1 activity within SPCs and spermatogonia in a wildtype setting, we now include whole mount analysis of wildtype seminiferous tubules using multiple markers of mTORC1 activation (see below). While we document striking changes in phosphorylation of downstream targets of the mTORC1 kinase complex during SPC commitment and spermatogonial differentiation, we do not find evidence of alterations in expression of mTORC1 pathway components themselves in the different cell subsets. For instance, we show that Tsc2, mTOR and the key downstream target 4EBP1 are ubiquitously expressed in the SPC pool and early differentiating spermatogonia despite changes in mTORC1 activity during differentiation commitment (Figs 2G, 4F and Supplementary Fig 2) . As discussed in the manuscript, changes to mTORC1 activity can be the result of dynamic alterations in growth factor stimulation.
In adults we find that the phosphorylation of ribosomal protein S6 (RPS6), a widely used indicator of mTORC1 activity, is primarily detected in long cysts of spermatogonia with low or absent Plzf expression, i.e. differentiating spermatogonia (Fig 1B) . This data is in agreement with our previous immunohistochemistry data ( Fig 1A) . However, as we now note in the manuscript, while phospho-RPS6 is a commonly used marker of mTORC1 activation and Tsc2 deletion results in substantial increases in phospho-RPS6 levels (Figs 1H and 3B), this marker may not provide the most sensitive and direct measure of mTORC1 activity. Specifically, phosphorylation of RPS6 is induced indirectly through mTORC1-dependent phosphorylation and activation of ribosomal S6 kinases (S6Ks). Further, S6Ks are phosphorylated and regulated by other kinases besides the mTORC1 complex, e.g. Pdk1, and thus integrate multiple regulatory inputs [3] . In addition, S6Ks are relatively poor, low affinity substrates for mTORC1 when compared to other direct targets [4] .
cysts stain for phospho-4EBP1 (Fig 1C and 1D ). Tools to detect the Ngn3-positive differentiation-prone SPC population are limited given the absence of appropriate antibodies and typical reliance on GFP reporter strains [10] . Therefore, we also provide data demonstrating that phospho-4EBP1 levels are strongly associated with expression of Lin28a (Supplementary Fig 1C) . This marker has been demonstrated to preferentially mark committed progenitors within the SPC pool [7] .
Given that efficient signaling through the mTORC1-S6K-RPS6 axis requires a higher overall level of mTORC1 activation than mTORC1-dependent 4EBP1 phosphorylation [4] , it can be concluded that the distinct patterns of 4EBP1 and RPS6 phosphorylation we observe in spermatogonial subsets indicate the relative levels to which mTORC1 is activated. Specifically, selfrenewing SPCs have low mTORC1 activity and stain weakly for both phospho-4EBP1 and phospho-RPS6. Differentiation-prone SPC subsets have an intermediate mTORC1 activity and are positive for phospho-4EBP1 but negative for phospho-RPS6. Differentiating spermatogonia have a high level of mTORC1 activation and are therefore positive for both phospho-4EBP1 and phospho-RPS6.
This conclusion is consistent with our previous data correlating incremental increases in cell size, an indicator of mTORC1 activity, with SPC differentiation commitment (Fig 6A-C) .
Based on these and previous observations, it is clear that mTORC1 pathway activity in the SPC pool is heterogeneous and preferentially associated with those SPC subsets with high propensity for differentiation. Given that aberrant mTORC1 activation in SPCs induced by efficient Vasa-Cre mediated deletion of Tsc2 results in increased differentiation commitment and germline degeneration, we conclude that this differential activation of mTORC1 underlies distinct differentiation and self-renewal propensities of SPC subsets.
Spermatogenesis of Tsc2 mutant mice.
In both the Stra8-Cre and Vasa-Cre models of Tsc2 deletion, histological assessment of the testis and/or epididymis confirms that mature spermatozoa are generated (Figs 2A and 3C ). These data indicate that regardless of the effects of Tsc2 deletion on SPC function, deletion of Tsc2 does not perturb the spermatogenic process. Indeed, although in the Tsc2 floxed Vasa-Cre model we observe loss of undifferentiated cells and consequent degeneration of many tubules in adults, a number of tubules in cross-sections appear to have a relatively unperturbed seminiferous epithelium and contain maturing spermatozoa (Fig 3C) . The Tsc2 floxed Stra8-Cre model has essentially identical tubule morphology to controls (Fig 2A) . While these results suggest that fertility would still be intact to differing extents in these models, it has not been directly assessed in the current study.
